News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,153 Results
Type
Article (46157)
Company Profile (360)
Press Release (666636)
Section
Business (212716)
Career Advice (2123)
Deals (37054)
Drug Delivery (95)
Drug Development (83705)
Employer Resources (171)
FDA (16566)
Job Trends (15685)
News (359635)
Policy (34559)
Tag
Academia (2682)
Africa (887)
Alliances (51808)
Alzheimer's disease (1166)
Approvals (16512)
Arizona (182)
Artificial intelligence (77)
Asia (40677)
Australia (6545)
Bankruptcy (369)
Best Places to Work (11528)
Biosimilars (66)
Biotechnology (236)
C2C Services and Suppliers (81838)
California (1614)
Canada (835)
Cancer (339)
Career advice (1774)
Cell therapy (106)
China (113)
Clinical research (65201)
Collaboration (111)
Colorado (66)
Connecticut (62)
COVID-19 (2610)
Cystic fibrosis (73)
Data (125)
Diabetes (67)
Diagnostics (6126)
Drug pricing (72)
Earnings (85927)
Employer resources (144)
Europe (86224)
Events (113102)
Executive appointments (91)
FDA (16735)
Florida (207)
Funding (94)
Gene therapy (82)
GLP-1 (546)
Government (4492)
Healthcare (19198)
Hotbed/Location (497696)
Illinois (240)
Indiana (139)
Infectious disease (2635)
Inflammatory bowel disease (94)
Interviews (328)
IPO (16571)
Job creations (4229)
Job search strategy (1530)
Kansas (93)
Layoffs (424)
Legal (8613)
Lung cancer (75)
Manufacturing (83)
Maryland (340)
Massachusetts (1321)
Medical device (13394)
Medtech (13397)
Mergers & acquisitions (20270)
Metabolic disorders (235)
Michigan (117)
Minnesota (203)
Neuroscience (1285)
New Jersey (484)
New York (483)
NextGen Class of 2024 (6842)
Non-profit (4626)
North Carolina (600)
Northern California (711)
Obesity (146)
Ohio (97)
Opinion (200)
Patents (60)
Pennsylvania (516)
People (58643)
Pharmaceutical (89)
Phase I (20131)
Phase II (28667)
Phase III (21554)
Pipeline (92)
Podcasts (61)
Postmarket research (2726)
Preclinical (8663)
Press Release (69)
Rare diseases (116)
Real estate (6488)
Recruiting (66)
Regulatory (22343)
Research institute (2420)
Resumes & cover letters (360)
South America (1232)
Southern California (637)
Startups (3809)
Texas (184)
United States (7538)
Vaccines (476)
Washington State (237)
Weight loss (133)
Date
Last 7 days (472)
Last 30 days (2220)
Last 365 days (38540)
2024 (25198)
2023 (41075)
2022 (52249)
2021 (56832)
2020 (55457)
2019 (48290)
2018 (36574)
2017 (33715)
2016 (33479)
2015 (39508)
2014 (33456)
2013 (28640)
2012 (30785)
2011 (31368)
2010 (29521)
713,153 Results for "millennium pharmaceuticals inc south san francisco california".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor
Astellas Pharma Inc. announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA.
May 8, 2024
·
3 min read
Biotech Bay
Nutcracker Therapeutics’ Research Partner, the University of California, San Francisco, Presents Foundational Prostate Cancer Data at AAI 2024
Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, detailed data presented by its partners at the University of California, San Francisco on foundational prostate cancer antigen research utilized to inform the development of its mRNA drug candidate, NTX-470.
May 15, 2024
·
4 min read
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
Dyadic International, Inc. today announced that Joseph Hazelton, Chief Business Officer and Doug Pace, Executive Vice President of Business Development will be attending the Future Food-Tech “Innovation & Investment from Farm to Fork” event March 21 – 22, 2024 at the San Francisco Marriott Marquis in California.
March 21, 2024
·
5 min read
Layoffs
Genentech to Lay Off 93 in San Francisco
Genentech’s latest layoffs are the second round of workforce reductions this year, following the company’s announcement in April that it was letting go around 3% of employees.
August 28, 2024
·
1 min read
·
Angela Gabriel
Business
Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times
The San Francisco Business Times has named Gladstone Institutes President Deepak Srivastava, MD, as one of the Most Admired CEOs among Bay Area businesses and nonprofits.
May 10, 2024
·
4 min read
Drug Development
OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21)
OSE Immunotherapeutics SA, presented a poster on preclinical data on its mRNA therapeutic platform for the treatment of inflammatory and autoimmune disorders at the Federation of Clinical Immunology Societies annual meeting held in San Francisco.
June 20, 2024
·
8 min read
Press Releases
MedGenome boosts omic insights capabilities as the first commercial provider in the San Francisco Bay Area of California to bring PacBio Revio in-house with full service capability
July 19, 2024
·
3 min read
Pharm Country
Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024
Acasti Pharma Inc. today announced that Chief Executive Officer Prashant Kohli will participate in the following investor and industry networking events in San Francisco, California during the week of January 7-12, 2024.
December 13, 2023
·
5 min read
Layoffs
FibroGen to Lay Off 127 Workers in San Francisco
FibroGen expects its headcount reduction, which is tied to eliminating 75% of its U.S. workforce, to be mostly complete by the end of the first quarter of 2025.
August 12, 2024
·
1 min read
·
Angela Gabriel
Biotech Bay
Veracyte Earns Top Workplace Awards in the San Francisco Bay Area and San Diego
Veracyte, Inc. announced that its South San Francisco and San Diego offices have been named top workplaces.
August 15, 2023
·
2 min read
1 of 71,316
Next